MegaPro Biomedical Overview
- Year Founded
-
2014
- Status
-
Public
- Employees
-
20
- Stock Symbol
-
6827
- Investments
-
1
- Share Price
-
$0.59
- (As of Friday Closing)
MegaPro Biomedical General Information
Description
MegaPro Biomedical Co Ltd is a nanomedicine development company. The Company's only reportable operating segment is the Drug Application Development segment, which is engaged in the development of nano-iron oxide IOP drugs.
Contact Information
Website
www.megaprobio.comCorporate Office
- Suite 526, Bldg.52, No.195, Sec.4
- Chung Hsing Rd
- Hsinchu, 310-40
- Taiwan
Corporate Office
- Suite 526, Bldg.52, No.195, Sec.4
- Chung Hsing Rd
- Hsinchu, 310-40
- Taiwan
MegaPro Biomedical Stock Performance
As of 20-Nov-2026, MegaPro Biomedical’s stock price is $0.59. Its current market cap is $71M with 121M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.59 | $0.70 | $0.29 - $0.73 | $71M | 121M | 721K | -$0.04 |
MegaPro Biomedical Financials Summary
As of 30-Jun-2026, MegaPro Biomedical has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 27,286 | 30,050 | 23,300 | 46,927 |
| Revenue | 0 | 0 | 1 | 1 |
| EBITDA | (2,970) | (3,420) | (4,735) | (3,716) |
| Net Income | (3,279) | (3,818) | (5,112) | (4,095) |
| Total Assets | 7,325 | 8,919 | 6,821 | 9,587 |
| Total Debt | 46 | 92 | 172 | 271 |
MegaPro Biomedical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MegaPro Biomedical Patents
MegaPro Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024432366-A1 | Iron-oxide nanoparticle-loaded mesenchymal stem cells and uses thereof | Pending | 04-Mar-2024 | ||
| WO-2025184767-A1 | Iron-oxide nanoparticle-loaded mesenchymal stem cells and uses thereof | Pending | 04-Mar-2024 | ||
| WO-2025184767-A8 | Iron-oxide nanoparticle-loaded mesenchymal stem cells and uses thereof | Pending | 04-Mar-2024 | ||
| AU-2019446285-A1 | Pharmaceutical compositions containing mixed polymeric micelles | Active | 16-May-2019 | ||
| AU-2019446285-B2 | Pharmaceutical compositions containing mixed polymeric micelles | Active | 16-May-2019 | A61K9/1075 |
MegaPro Biomedical Signals
MegaPro Biomedical Investments (1)
MegaPro Biomedical’s most recent deal was a Joint Venture with JV Trium Therapeutics (CCPC/ MegaPro / Wellbridge). The deal was made on 14-Jul-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| JV Trium Therapeutics (CCPC/ MegaPro / Wellbridge) | 14-Jul-2022 | Joint Venture | Drug Discovery |
MegaPro Biomedical ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
MegaPro Biomedical FAQs
-
When was MegaPro Biomedical founded?
MegaPro Biomedical was founded in 2014.
-
Where is MegaPro Biomedical headquartered?
MegaPro Biomedical is headquartered in Hsinchu, Taiwan.
-
What is the size of MegaPro Biomedical?
MegaPro Biomedical has 20 total employees.
-
What industry is MegaPro Biomedical in?
MegaPro Biomedical’s primary industry is Drug Discovery.
-
Is MegaPro Biomedical a private or public company?
MegaPro Biomedical is a Public company.
-
What is MegaPro Biomedical’s stock symbol?
The ticker symbol for MegaPro Biomedical is 6827.
-
What is the current stock price of MegaPro Biomedical?
As of 20-Nov-2026 the stock price of MegaPro Biomedical is $0.59.
-
What is the current market cap of MegaPro Biomedical?
The current market capitalization of MegaPro Biomedical is $71M.
-
What is MegaPro Biomedical’s annual earnings per share (EPS)?
MegaPro Biomedical’s EPS for 12 months was -$0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process